We are live on
!
Find out more
LP
Lexington Partners Portfolio holdings
AUM
$134M
1-Year Est. Return
1.93%
This Fund
S&P 500
This Quarter
Est. Return
+20%
1 Year Est. Return
-1.93%
3 Year Est. Return
+1.27%
5 Year Est. Return
-12.6%
10 Year Est. Return
–
AUM
$160M
AUM Growth
+$31.8M
(+25%)
Cap. Flow
+$2.69M
Cap. Flow
% of AUM
1.68%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avantor
AVTR
|
+$28.4M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$785K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.95% |
| 2 | Technology | 33.33% |
| 3 | Consumer Staples | 18.73% |
Similar funds
RA
SWM
SA
SA
GEH
BGI
MMCM
STFP
Lexington Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Lexington Partners held 4 positions worth $160M, up 25% from $128M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Lexington Partners's Q3 2020 filing shows 1 new, 1 reduced and 1 closed positions. Its largest new stake was Keurig Dr Pepper: 1,086,627 shares worth $30M. The largest sale was Avantor, an estimated $28.4M.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 64% a quarter earlier, followed by Technology and Consumer Staples.
- Lexington Partners's largest Q3 2020 buy was Keurig Dr Pepper: 1,086,627 shares worth $30M.
- Lexington Partners's biggest Q3 2020 reduction was Avantor, cutting an estimated $28.4M.
- Lexington Partners fully exited IVERIC bio, Inc. Common Stock in Q3 2020, selling an estimated $785K.
- Lexington Partners's ten largest holdings make up 100% of its $160M portfolio in Q3 2020.
- Lexington Partners opened 1 new position and closed 1 in Q3 2020.
- Lexington Partners's portfolio value rose 25% quarter-over-quarter to $160M.
Based on Lexington Partners's 13F filing for Q3 2020, filed 13 Nov 2020.